Noticias y Actividades de Sonoma Pharmaceuticals

Sonoma Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización SNOA (US).

Sonoma Pharmaceuticals tiene presencia directa en 2 países.

Ver el organigrama con sus 10 ejecutivos principales

Biografías más buscadas en Sonoma Pharmaceuticals

• Amy Trombly, Interim Chief Executive Officer
• Jerry McLaughlin, Director
• Jay Birnbaum, Independent Director

Crear su alerta
para seguir los movimientos de los ejecutivos en Sonoma Pharmaceuticals.

Sonoma Pharmaceuticals tiene 1.834 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).

Popular M&A news in Farmacia

• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
• Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado el 12 de marzo de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Paul Meister - Chairman of the Board en Amneal Pharmaceuticals

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Sonoma Pharmaceuticals

• Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
• Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
• Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
• Press Releases
• Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
• Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
• Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
• Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
• Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
• Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
• View more press releases Close

Redes sociales sobre Sonoma Pharmaceuticals

• Sonoma Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• Sonoma Pharmaceuticals en LinkedIn, Twitter y YouTube